Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ITPKB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SLC9A9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FAM122A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBE2J2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPOR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H2AK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM232 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ICOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXL17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMK2N1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC401021 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STXBP5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on